allodynia and glp 1 treatment is being reported with GLP-1 medications It is a heightened sensitivity tirzepatide allodynia and semaglutide: complete

The KPV in KLOW is less directly relevant to follicular mechanisms unless the research specifically examines inflammatory-driven hair loss

Renal impairment GLP-1 RAs are generally safe in patients with CKD and have demonstrated nephroprotective effects in the FLOW trial, where semaglutide significantly reduced the composite renal endpoint (hospitalization for acute kidney injury, sustained 50% decline in estimated glomerular filtration rate (eGFR), end-stage kidney disease, or renal death) in patients with type 2 diabetes and CKD [15]

Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study

No association with the 5,10-methylenetetrahydrofolate reductase gene and major depressive disorder: results of the depression case control (DeCC) study and a meta-analysis

It can remain elevated even from occasional drinking

SubaranSCSauderMAChaiWJahnLAFowlerDEAylorKWet alGLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans